Developer of a novel implantable device designed to treat erectile dysfunction. Comphya is based in Lausanne, Switzerland. Its last reported valuation was $80.8 million in Jul 2025. It has raised $16.8 million.
Last reported valuation
$80.8M
Oct 2026
Priced at
—
Total raised
$16.8M
Last round
—
How much has Comphya raised?
$16.8Macross 0 recorded rounds
Free account
More of Comphya with a free account
·The complete investor list: 11 names
·Watch Comphya: the Monday email on marks, rounds and moves